| Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ... PloS one 4 (3), e4724, 2009 | 1130 | 2009 |
| Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets VJ Munster, E de Wit, JMA van den Brand, S Herfst, EJA Schrauwen, ... Science 325 (5939), 481-483, 2009 | 772 | 2009 |
| Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) JJA van Kampen, DAMC van de Vijver, PLA Fraaij, BL Haagmans, ... Nature communications 12 (1), 267, 2021 | 705 | 2021 |
| An automated genotyping system for analysis of HIV-1 and other microbial sequences T De Oliveira, K Deforche, S Cassol, M Salminen, D Paraskevis, ... Bioinformatics 21 (19), 3797-3800, 2005 | 594 | 2005 |
| Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ... The Journal of infectious diseases 192 (6), 958-966, 2005 | 562 | 2005 |
| Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures MK Hayden, MJM Bonten, DW Blom, EA Lyle, DAMC van de Vijver, ... Clinical Infectious Diseases 42 (11), 1552-1560, 2006 | 556 | 2006 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 407 | 2022 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The Lancet gastroenterology and hepatology, 2017 | 328 | 2017 |
| Transmission of drug-resistant HIV-1 is stabilizing in Europe J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ... The Journal of infectious diseases 200 (10), 1503-1508, 2009 | 311 | 2009 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 285 | 2015 |
| Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants JJA van Kampen, DAMC van de Vijver, PLA Fraaij, BL Haagmans, ... MedRxiv, 2020.06. 08.20125310, 2020 | 252 | 2020 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 243 | 2014 |
| Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world D Frentz, CA Boucher, DA Van De Vijver AIDs Rev 14 (1), 17-27, 2012 | 202 | 2012 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 190 | 2016 |
| HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ... Retrovirology 10, 1-13, 2013 | 186 | 2013 |
| Declining hepatitis C virus (HCV) incidence in Dutch human immunodeficiency virus-positive men who have sex with men after unrestricted access to HCV therapy A Boerekamps, GE Van den Berk, FN Lauw, EM Leyten, ME Van Kasteren, ... Clinical Infectious Diseases 66 (9), 1360-1365, 2018 | 184* | 2018 |
| Sustainable HIV treatment in Africa through viral-load-informed differentiated care A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ... Nature 528 (7580), S68-S76, 2015 | 174 | 2015 |
| Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ... Retrovirology 6, 1-11, 2009 | 154 | 2009 |
| The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes DA Van De Vijver, AMJ Wensing, G Angarano, B Åsjö, C Balotta, E Boeri, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (3), 352-360, 2006 | 137 | 2006 |
| Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study BE Nichols, CAB Boucher, M van der Valk, BJA Rijnders, ... The Lancet Infectious Diseases 16 (12), 1423-1429, 2016 | 129 | 2016 |
